138 related articles for article (PubMed ID: 32848420)
21. Genetic heterogeneity and predictive biomarker for pulmonary sarcomatoid carcinomas.
Qin J; Chen B; Li C; Yan J; Lu H
Cancer Genet; 2021 Jan; 250-251():12-19. PubMed ID: 33217678
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition.
Kwon D; Ronen S; Giubellino A; Keiser E; Aung PP; Nagarajan P; Tetzlaff MT; Ivan D; Curry JL; Prieto VG; Torres-Cabala CA
J Cutan Pathol; 2021 Apr; 48(4):526-534. PubMed ID: 32564423
[TBL] [Abstract][Full Text] [Related]
23. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects.
Torenbeek R; Hermsen MA; Meijer GA; Baak JP; Meijer CJ
J Pathol; 1999 Nov; 189(3):338-43. PubMed ID: 10547594
[TBL] [Abstract][Full Text] [Related]
24. Review article: pulmonary sarcomatoid carcinomas: a practical overview.
Pelosi G; Sonzogni A; De Pas T; Galetta D; Veronesi G; Spaggiari L; Manzotti M; Fumagalli C; Bresaola E; Nappi O; Viale G; Rosai J
Int J Surg Pathol; 2010 Apr; 18(2):103-20. PubMed ID: 19124452
[TBL] [Abstract][Full Text] [Related]
25. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.
Liu P; Morrison C; Wang L; Xiong D; Vedell P; Cui P; Hua X; Ding F; Lu Y; James M; Ebben JD; Xu H; Adjei AA; Head K; Andrae JW; Tschannen MR; Jacob H; Pan J; Zhang Q; Van den Bergh F; Xiao H; Lo KC; Patel J; Richmond T; Watt MA; Albert T; Selzer R; Anderson M; Wang J; Wang Y; Starnes S; Yang P; You M
Carcinogenesis; 2012 Jul; 33(7):1270-6. PubMed ID: 22510280
[TBL] [Abstract][Full Text] [Related]
26. Integrin-linked kinase pathway in heterogeneous pulmonary sarcomatoid carcinoma.
Shimizu S; Sakai K; Chikugo T; Satou T; Shiraishi N; Mitsudomi T; Nishio K
Oncol Lett; 2021 Apr; 21(4):320. PubMed ID: 33692852
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of
Yu Y; Zhang Q; Zhang J; Lu S
J Cancer Res Ther; 2019; 15(4):909-913. PubMed ID: 31436251
[TBL] [Abstract][Full Text] [Related]
28. Ovarian Carcinosarcoma and Concurrent Serous Tubal Intraepithelial Carcinoma With Next-Generation Sequencing Suggesting an Origin From the Fallopian Tube.
See SHC; Behdad A; Maniar KP; Blanco LZ
Int J Surg Pathol; 2019 Aug; 27(5):574-579. PubMed ID: 30913944
[No Abstract] [Full Text] [Related]
29. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
[TBL] [Abstract][Full Text] [Related]
30. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing.
Zhang X; Bai Q; Xu Y; Wang W; Chen L; Han J; Zhu H; Zhang Z; Hou Y; Zhou J; Zhou Y; Ji Y
Histopathology; 2019 May; 74(6):944-958. PubMed ID: 30629754
[TBL] [Abstract][Full Text] [Related]
32. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
33. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
[TBL] [Abstract][Full Text] [Related]
34. Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Zhao Y; Dong Y; Zhao R; Zhang B; Wang S; Zhang L; Hu M; He Q; Zhang W; Han B
Clin Lung Cancer; 2020 Sep; 21(5):e355-e362. PubMed ID: 32139332
[TBL] [Abstract][Full Text] [Related]
35. Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas.
Robinson LA; Babacan NA; Tanvetyanon T; Henderson-Jackson E; Bui MM; Druta M
J Thorac Cardiovasc Surg; 2021 Jul; 162(1):274-284. PubMed ID: 32711968
[TBL] [Abstract][Full Text] [Related]
36. Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.
Pelosi G; Gasparini P; Conte D; Fabbri A; Perrone F; Tamborini E; Pupa SM; Ciravolo V; Caserini R; Rossi G; Cavazza A; Papotti M; Nakatani Y; Maisonneuve P; Pastorino U; Sozzi G
J Thorac Oncol; 2016 May; 11(5):718-728. PubMed ID: 26804638
[TBL] [Abstract][Full Text] [Related]
37. New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles.
Nakagomi T; Goto T; Hirotsu Y; Shikata D; Yokoyama Y; Higuchi R; Amemiya K; Okimoto K; Oyama T; Mochizuki H; Omata M
Oncotarget; 2018 Feb; 9(12):10635-10649. PubMed ID: 29535832
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing.
Paniz-Mondolfi A; Singh R; Jour G; Mahmoodi M; Diwan AH; Barkoh BA; Cason R; Huttenbach Y; Benaim G; Galbincea J; Luthra R
Virchows Arch; 2014 Sep; 465(3):339-50. PubMed ID: 25031014
[TBL] [Abstract][Full Text] [Related]
39. The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer.
Cai J; Jiang H; Li S; Yan X; Wang M; Li N; Zhu C; Dong H; Wang D; Xu Y; Xie H; Wu S; Lou J; Zhao J; Li Q
Front Oncol; 2021; 11():751106. PubMed ID: 35273907
[TBL] [Abstract][Full Text] [Related]
40. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung.
Vieira T; Antoine M; Ruppert AM; Fallet V; Duruisseaux M; Giroux Leprieur E; Poulot V; Rabbe N; Sclick L; Beau-Faller M; Lacave R; Lavole A; Cadranel J; Wislez M
Lung Cancer; 2014 Aug; 85(2):276-81. PubMed ID: 24997135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
